| 臺大學術典藏 |
2020-11-27T03:28:38Z |
Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of Helicobacter pylori in the community and hospital populations: A randomised trial
|
Wu M.-S.; the Taiwan Gastrointestinal Disease; Helicobacter Consortium; Shun C.-T.; Lin J.-T.; Lee Y.-C.; Tsao F.-Y.; Liu T.-Y.; Hsieh C.-F.; Bair M.-J.; Liou J.-M.; CHIEH-CHANG CHEN; Chang C.-Y.; Chen M.-J.; Chien-Chuan Chen; Fang Y.-J.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Liou T.-C.; Chang W.-H.; Hsu Y.-C.; Tseng C.-H.; Chang C.-C. |
| 臺大學術典藏 |
2020-11-27T03:28:38Z |
Association Between Serum Level of Hepatitis B Surface Antigen at End of Entecavir Therapy and Risk of Relapse in E Antigen–Negative Patients
|
Hsu Y.-C.; Mo L.-R.; Chang C.-Y.; Wu M.-S.; Kao J.-H.; Wang W.-L.; Yang T.-H.; Wang C.-S.; Chiang M.-F.; CHIEH-CHANG CHEN; Fang Y.-J.; Hung H.-W.; Wu C.-Y.; Lin J.-T. |
| 臺大學術典藏 |
2020-11-27T03:28:38Z |
Levofloxacin sequential therapy vs levofloxacin triple therapy in the second-line treatment of helicobacter pylori: A randomized trial
|
Liou J.-M.; Bair M.-J.; CHIEH-CHANG CHEN; Lee Y.-C.; Chen M.-J.; Chien-Chuan Chen; Tseng C.-H.; Fang Y.-J.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Chang W.-H.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hung H.-W.; Lin J.-T.; Chang C.-Y.; Wu M.-S. |
| 臺大學術典藏 |
2020-11-27T03:28:37Z |
Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial
|
Liou J.-M.; Fang Y.-J.; CHIEH-CHANG CHEN; Bair M.-J.; Chang C.-Y.; Lee Y.-C.; Chen M.-J.; Chien-Chuan Chen; Tseng C.-H.; Hsu Y.-C.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hu W.-H.; Chen Y.-N.; Sheu B.-S.; Lin J.-T.; Wu J.-Y.; El-Omar E.M.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2020-11-27T03:28:36Z |
14 Day sequential therapy versus 10 day bismuth quadruple therapy containing high-dose esomeprazole in the first-line and second-line treatment of Helicobacter pylori: A multicentre, non-inferiority, randomized trial
|
Liou J.-M.; CHIEH-CHANG CHEN; Fang Y.-J.; Chen P.-Y.; Chang C.-Y.; Chou C.-K.; Chen M.-J.; Tseng C.-H.; Lee J.-Y.; Yang T.-H.; Chiu M.-C.; Yu J.-J.; Kuo C.-C.; Luo J.-C.; Hsu W.-F.; Hu W.-H.; Tsai M.-H.; Lin J.-T.; Shun C.-T.; Twu G.; Lee Y.-C.; Bair M.-J.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2020-11-27T03:28:36Z |
Impact of amoxicillin resistance on the efficacy of amoxicillincontaining regimens for Helicobacter pylori eradication: Analysis of five randomized trials
|
Chen M.-J.; Wu M.-S.; Chien-Chuan Chen; CHIEH-CHANG CHEN; Fang Y.-J.; Bair M.-J.; Chang C.-Y.; Lee J.-Y.; Hsu W.-F.; Luo J.-C.; Lin J.-T.; Liou J.-M.; on behalf of the Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2020-11-27T03:28:35Z |
Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection
|
Liou J.-M.; Chen P.-Y.; Luo J.-C.; Lee J.-Y.; CHIEH-CHANG CHEN; Fang Y.-J.; Yang T.-H.; Chang C.-Y.; Bair M.-J.; Chen M.-J.; Hsu Y.-C.; Hsu W.-F.; Chang C.-C.; Lin J.-T.; Shun C.-T.; El-Omar E.M.; Wu M.-S.; Liou J.-M.; Lee Y.-C.; Lin J.-T.; Wu C.-Y.; Wu J.-Y.; Chun-Chao Chang; Lin C.-H.; Fang Y.-R.; Bair M.-J.; Luo J.-C.; Wu M.-S.; Cheng T.-Y.; Tseng P.-H.; Chiu H.-M.; Chang C.-C.; Yu C.-C.; Chiu M.-C.; Chen Y.-N.; Hu W.-H.; Chou C.-K.; Tai C.-M.; Lee C.-T.; Wang W.-L.; Chang W.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2020-11-27T03:28:35Z |
Systematic Review with Meta-Analysis: Concomitant Therapy vs. Triple Therapy for the First-Line Treatment of Helicobacter pylori Infection
|
Chen M.-J.; Chien-Chuan Chen; Chen Y.-N.; CHIEH-CHANG CHEN; Fang Y.-J.; Lin J.-T.; Wu M.-S.; Liou J.-M.; for the Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2020-11-27T03:28:33Z |
Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial
|
Liou J.-M.; CHIEH-CHANG CHEN; Chang C.-M.; Fang Y.-J.; Bair M.-J.; Chen P.-Y.; Chang C.-Y.; Hsu Y.-C.; Chen M.-J.; Chien-Chuan Chen; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chen C.-Y.; Hsu W.-F.; Chen Y.-N.; Wu J.-Y.; Lin J.-T.; Lu T.-P.; Chuang E.Y.; El-Omar E.M.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2020-11-27T03:28:32Z |
Application of Helicobacter pylori stool antigen test to survey the updated prevalence of Helicobacter pylori infection in Taiwan
|
Chen M.-J.; Fang Y.-J.; Wu M.-S.; CHIEH-CHANG CHEN; Chen Y.-N.; Yu C.-C.; Kuo C.-C.; Chiu M.-C.; Hu W.-H.; Tsai M.-H.; Hsieh C.-L.; Chen H.-H.; Bair M.-J.; Liou J.-M.; for the Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2020-11-27T03:28:32Z |
Comparison of DNA stabilizers and storage conditions on preserving fecal microbiota profiles
|
Liou J.-M.; Fang Y.-J.; Chuang E.Y.; Wu M.-S.; CHIEH-CHANG CHEN; Wu W.-K.; Chang C.-M.; Panyod S.; Lu T.-P. |
| 臺大學術典藏 |
2020-11-27T03:28:32Z |
Comparison of the effect of clarithromycin triple therapy with or without N-acetylcysteine in the eradication of Helicobacter pylori: a randomized controlled trial
|
CHIEH-CHANG CHEN; Luo J.-C.; Fang Y.-J.; Lee J.-Y.; Kuo C.-C.; Yang T.-H.; Chiu M.-C.; Yu J.-J.; Bair M.-J.; Chen P.-Y.; Chou C.-K.; Chen C.-Y.; Chang C.-Y.; Hsu Y.-C.; Tseng C.-H.; Hsu W.-F.; Hu W.-H.; Tsai M.-H.; Hsieh C.-L.; Chen M.-J.; Shun C.-T.; Liu T.-Y.; Lee§ Y.-C.; Liou§ J.-M.; Wu§ M.-S.; and for the Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2020-11-27T03:28:31Z |
Accuracy of rapid Helicobacter pylori antigen tests for the surveillance of the updated prevalence of H. pylori in Taiwan
|
Fang Y.-J.; Chen M.-J.; CHIEH-CHANG CHEN; Lee J.-Y.; Yang T.-H.; Yu C.-C.; Chiu M.-C.; Kuo C.-C.; Weng Y.-J.; Bair M.-J.; Wu M.-S.; Luo J.-C.; Liou J.-M. |
| 臺大學術典藏 |
2020-11-17T02:45:18Z |
Comparison of DNA stabilizers and storage conditions on preserving fecal microbiota profiles
|
Wu M.-S.; Chuang E.Y.; Fang Y.-J.; TZU-PIN LU; Liou J.-M.; Panyod S.; Chang C.-M.; Wu W.-K.; Chen C.-C.; Chen C.-C.;Wu W.-K.;Chang C.-M.;Panyod S.;Tzu-Pin Lu;Liou J.-M.;Fang Y.-J.;Chuang E.Y.;Wu M.-S. |
| 臺大學術典藏 |
2020-11-03T08:19:39Z |
Elbasvir/grazoprevir for hepatitis C virus genotype 1b East-Asian patients receiving hemodialysis
|
CHEN-HUA LIU; Peng C.-Y.; Fang Y.-J.; Kao W.-Y.; Yang S.-S.; Lin C.-K.; Lai H.-C.; Su W.-P.; Fang S.-U.; Chang C.-C.; Su T.-H.; Liu C.-J.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2020-11-03T07:37:19Z |
Suggested cutoff tumor size for management of small EUS-suspected gastric gastrointestinal stromal tumors
|
Wang H.-P.; WEI-CHIH LIAO; Chen J.-H.; Yang C.-S.; Sun M.-S.; Cheng T.-Y.; Fang Y.-J. |
| 臺大學術典藏 |
2020-11-02T02:04:52Z |
Empirical modified sequential therapy containing levofloxacin and high-dose esomeprazole in second-line therapy for Helicobacter pylori infection: A multicentre clinical trial
|
Liou J.-M.; Chen C.-C.; Chen M.-J.; Chang C.-Y.; Fang Y.-J.; Lee J.-Y.; Sheng W.-H.; Wang H.-P.; MING-SHIANG WU; Lin J.-T. |
| 臺大學術典藏 |
2020-11-02T02:04:49Z |
Randomised clinical trial: High-dose vs. standard-dose proton pump inhibitors for the prevention of recurrent haemorrhage after combined endoscopic haemostasis of bleeding peptic ulcers
|
Chen C.-C.; Lee J.-Y.; Fang Y.-J.; Hsu S.-J.; Han M.-L.; Tseng P.-H.; Liou J.-M.; Hu F.-C.; Lin T.-L.; MING-SHIANG WU; Wang H.-P.; Lin J.-T. |
| 臺大學術典藏 |
2020-11-02T02:04:47Z |
Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: A multicentre, open-label, randomised trial
|
MING-SHIANG WU; Lee Y.-C.; Liou J.-M.; Chen C.-C.; Chen M.-J.; Chen C.-C.; Chang C.-Y.; Fang Y.-J.; Lee J.-Y.; Hsu S.-J.; Luo J.-C.; Chang W.-H.; Hsu Y.-C.; Tseng C.-H.; Tseng P.-H.; Wang H.-P.; Yang U.-C.; Shun C.-T.; Lin J.-T. |
| 臺大學術典藏 |
2020-11-02T02:04:45Z |
Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: A multicentre clinical trial
|
Tai C.-M.; Wang Y.-C.; Wang C.-H.; Kuo S.-H.; Wu C.-Y.; Chang W.-H.; Wang H.-P.; Shun C.-T.; Wu J.-Y.; Lee Y.-C.; Lin J.-T.; MING-SHIANG WU; Lin C.-H.; Chow L.-P.; Cheng T.-Y.; Wu C.-Y.; Lee Ching-Tai C.-T, Wang W.-L.; Liou J.-M.; Chen C.-C.; Chang C.-Y.; Chen M.-J.; Fang Y.-J.; Lee J.-Y.; Chen C.-C.; Hsu S.-J.; Hsu Y.-C.; Tseng C.-H.; Tseng P.-H.; Chang L. |
| 臺大學術典藏 |
2020-11-02T02:04:33Z |
The primary resistance of Helicobacter pylori in Taiwan after the national policy to restrict antibiotic consumption and its relation to virulence factors - A nationwide study
|
Lee Y.-C.; Wang W.-L.; Lee C.-T.; Tai C.-M.; MING-SHIANG WU; Bair M.-J.; Lin J.-T.; Sheu B.-S.; Wang H.-P.; Chang C.-C.; Yang T.-H.; Wu C.-Y.; Liou J.-M.; Chang C.-Y.; Chen M.-J.; Chen C.-C.; Fang Y.-J.; Lee J.-Y.; Wu J.-Y.; Luo J.-C.; Liou T.-C.; Chang W.-H.; Tseng C.-H.; Helicobacter Consortium; Taiwan Gastrointestinal Disease; Wang Y.-C. |
| 臺大學術典藏 |
2020-11-02T02:04:26Z |
Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of Helicobacter pylori in the community and hospital populations: A randomised trial
|
Helicobacter Consortium; Fang Y.-J.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Liou T.-C.; Chang W.-H.; Hsu Y.-C.; Tseng C.-H.; Chang C.-C.; Bair M.-J.; Liu T.-Y.; Hsieh C.-F.; Tsao F.-Y.; Shun C.-T.; Lin J.-T.; Lee Y.-C.; MING-SHIANG WU; the Taiwan Gastrointestinal Disease; Liou J.-M.; Chen C.-C.; Chang C.-Y.; Chen M.-J.; Chen C.-C. |
| 臺大學術典藏 |
2020-11-02T02:04:26Z |
Association Between Serum Level of Hepatitis B Surface Antigen at End of Entecavir Therapy and Risk of Relapse in E Antigen�VNegative Patients
|
Lin J.-T.; Wu C.-Y.; Hung H.-W.; Fang Y.-J.; Chen C.-C.; Chiang M.-F.; Wang C.-S.; Yang T.-H.; Wang W.-L.; Kao J.-H.; MING-SHIANG WU; Chang C.-Y.; Hsu Y.-C.; Mo L.-R. |
| 臺大學術典藏 |
2020-11-02T02:04:25Z |
Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial
|
Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hu W.-H.; Chen Y.-N.; Sheu B.-S.; Lin J.-T.; Wu J.-Y.; El-Omar E.M.; MING-SHIANG WU; Taiwan Gastrointestinal Disease; Helicobacter Consortium; Chang C.-C.; Luo J.-C.; Yang T.-H.; Lee J.-Y.; Hsu Y.-C.; Chen C.-C.; Tseng C.-H.; Chen M.-J.; Lee Y.-C.; Chang C.-Y.; Bair M.-J.; Chen C.-C.; Fang Y.-J.; Liou J.-M. |
| 臺大學術典藏 |
2020-11-02T02:04:20Z |
Impact of amoxicillin resistance on the efficacy of amoxicillincontaining regimens for Helicobacter pylori eradication: Analysis of five randomized trials
|
Chen M.-J.; MING-SHIANG WU; Chen C.-C.; Chen C.-C.; Fang Y.-J.; Bair M.-J.; Chang C.-Y.; Lee J.-Y.; Hsu W.-F.; Luo J.-C.; Lin J.-T.; Liou J.-M.; on behalf of the Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2020-11-02T02:04:19Z |
14 Day sequential therapy versus 10 day bismuth quadruple therapy containing high-dose esomeprazole in the first-line and second-line treatment of Helicobacter pylori: A multicentre, non-inferiority, randomized trial
|
Liou J.-M.; Chen C.-C.; Fang Y.-J.; Chen P.-Y.; Chang C.-Y.; Chou C.-K.; Chen M.-J.; Tseng C.-H.; Lee J.-Y.; Yang T.-H.; Chiu M.-C.; Yu J.-J.; Kuo C.-C.; Luo J.-C.; Hsu W.-F.; Helicobacter Consortium; Taiwan Gastrointestinal Disease; MING-SHIANG WU; Bair M.-J.; Lee Y.-C.; Hu W.-H.; Tsai M.-H.; Lin J.-T.; Shun C.-T.; Twu G. |
| 臺大學術典藏 |
2020-11-02T02:04:13Z |
Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection
|
Liou J.-M.; Chen P.-Y.; Luo J.-C.; Lee J.-Y.; Helicobacter Consortium; Taiwan Gastrointestinal Disease; Chen C.-C.; Fang Y.-J.; Yang T.-H.; Chang C.-Y.; Bair M.-J.; Chen M.-J.; Hsu Y.-C.; Hsu W.-F.; Chang C.-C.; Lin J.-T.; Shun C.-T.; El-Omar E.M.; MING-SHIANG WU; Liou J.-M.; Lee Y.-C.; Lin J.-T.; Wu C.-Y.; Wu J.-Y.; Chen C.-C.; Lin C.-H.; Fang Y.-R.; Bair M.-J.; Luo J.-C.; MING-SHIANG WU; Cheng T.-Y.; Tseng P.-H.; Chiu H.-M.; Chang C.-C.; Yu C.-C.; Chiu M.-C.; Chen Y.-N.; Hu W.-H.; Chou C.-K.; Tai C.-M.; Lee C.-T.; Wang W.-L.; Chang W.-S. |
| 臺大學術典藏 |
2020-11-02T02:04:03Z |
Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial
|
Helicobacter Consortium; Taiwan Gastrointestinal Disease; MING-SHIANG WU; El-Omar E.M.; Chuang E.Y.; Lu T.-P.; Lin J.-T.; Wu J.-Y.; Chen Y.-N.; Hsu W.-F.; Chen C.-Y.; Luo J.-C.; Yang T.-H.; Lee J.-Y.; Chen C.-C.; Liou J.-M.; Chen C.-C.; Chang C.-M.; Fang Y.-J.; Bair M.-J.; Chen P.-Y.; Chang C.-Y.; Hsu Y.-C.; Chen M.-J. |
| 臺大學術典藏 |
2020-11-02T02:04:02Z |
Comparison of DNA stabilizers and storage conditions on preserving fecal microbiota profiles
|
MING-SHIANG WU; Chuang E.Y.; Fang Y.-J.; Liou J.-M.; Lu T.-P.; Panyod S.; Chang C.-M.; Chen C.-C.; Wu W.-K. |
| 臺大學術典藏 |
2020-07-05T03:14:28Z |
Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial
|
Wu M.-S.; Lee Y.-C.; Lin J.-T.; CHIA-TUNG SHUN; Yang U.-C.; Wang H.-P.; Lee J.; Hsu S.-J.; Luo J.-C.; Chang W.-H.; Hsu Y.-C.; Tseng C.-H.; Tseng P.-H.; Fang Y.-J.; Chang C.-Y.; Liou J.-M.; Chen C.-C.; Chen M.-J.; Chen C.-C. |
| 臺大學術典藏 |
2020-03-27T02:03:42Z |
Barium appendicitis
|
Fang Y.-J.; Wang H.-P.; Ho C.-M.; KAO-LANG LIU |
| 臺大學術典藏 |
2020-03-05T05:51:26Z |
Bleeding from ileal nodular lymphoid polyposis identified by capsule endoscopy
|
Wu J.-F.;Liou J.-H.;Huang-Chun Lien;Hsu W.-M.;Fang Y.-J.;Chang M.-H.;Ni Y.-H.; Wu J.-F.; Liou J.-H.; HUANG-CHUN LIEN; Hsu W.-M.; Fang Y.-J.; Chang M.-H.; Ni Y.-H. |
| 臺大學術典藏 |
2020-03-05T03:20:35Z |
Bleeding from ileal nodular lymphoid polyposis identified by capsule endoscopy
|
Wu J.-F.;Liou J.-H.;Lien H.-C.;Wen-Ming Hsu;Fang Y.-J.;Chang M.-H.;Ni Y.-H.; Wu J.-F.; Liou J.-H.; Lien H.-C.; WEN-MING HSU; Fang Y.-J.; Chang M.-H.; Ni Y.-H. |
| 臺大學術典藏 |
2020-02-11T03:54:01Z |
Barium appendicitis
|
Fang Y.-J.; Wang H.-P.; CHENG-MAW HO; Liu K.-L. |
| 國立臺灣科技大學 |
2020 |
Micrography QR Codes
|
Hung, S.-H.;Yao, C.-Y.;Fang, Y.-J.;Tan, P.;Lee, R.-R.;Sheffer, A.;Chu, H.-K. |
| 臺大學術典藏 |
2020 |
Accuracy of rapid Helicobacter pylori antigen tests for the surveillance of the updated prevalence of H. pylori in Taiwan
|
Liou J.-M.; Luo J.-C.; MING-SHIANG WU; Bair M.-J.; Kuo C.-C.; Weng Y.-J.; Chiu M.-C.; Yu C.-C.; Lee J.-Y.; Yang T.-H.; Chen C.-C.; Chen M.-J.; Fang Y.-J. |
| 臺大學術典藏 |
2020 |
Application of Helicobacter pylori stool antigen test to survey the updated prevalence of Helicobacter pylori infection in Taiwan
|
Bair M.-J.; Liou J.-M.; for the Taiwan Gastrointestinal Disease; Helicobacter Consortium; Chen H.-H.; Tsai M.-H.; Hsieh C.-L.; Chiu M.-C.; Hu W.-H.; Kuo C.-C.; Yu C.-C.; Chen Y.-N.; Chen C.-C.; MING-SHIANG WU; Fang Y.-J.; Chen M.-J. |
| 臺大學術典藏 |
2019 |
Real-world effectiveness and safety of glecaprevir/pibrentasvir in Asian patients with chronic hepatitis C
|
Hsu S.-J.; Chiu M.-C.; Fang Y.-J.; Yang T.-H.; Yu J.-J.; CHIEH-CHANG CHEN; Kuo C.-C.; Lee J.-Y.; Chen C.-H.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2019 |
Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial
|
Helicobacter Consortium; Taiwan Gastrointestinal Disease; Wu M.-S.; El-Omar E.M.; Liou J.-M.;Chen C.-C.;Chang C.-M.;Fang Y.-J.;Bair M.-J.;Chen P.-Y.;Chang C.-Y.;Hsu Y.-C.;Chen M.-J.;Chen C.-C.;Lee J.-Y.;Yang T.-H.;Luo J.-C.;Chen C.-Y.;Hsu W.-F.;Chen Y.-N.;Wu J.-Y.;Lin J.-T.;Tzu-Pin Lu;Chuang E.Y.;El-Omar E.M.;Wu M.-S.;Taiwan Gastrointestinal Disease;Helicobacter Consortium; Liou J.-M.; Chen C.-C.; Chang C.-M.; Fang Y.-J.; Bair M.-J.; Chen P.-Y.; Chang C.-Y.; Hsu Y.-C.; Chen M.-J.; Chen C.-C.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chen C.-Y.; Hsu W.-F.; Chen Y.-N.; Wu J.-Y.; Lin J.-T.; TZU-PIN LU; Chuang E.Y. |
| 國立成功大學 |
2019 |
Paritaprevir/ritonavir, ombitasvir plus dasabuvir for East Asian non-cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysis
|
Liu, C.-H.;Shih, Y.-L.;Yang, S.-S.;Lin, C.-L.;Fang, Y.-J.;Cheng, P.-N.;Chen, Chen C.-Y.;Peng, C.-Y.;Hsieh, T.-Y.;Chiu, Y.-C.;Su, T.-H.;Liu, C.-J.;Yang, H.-C.;Chen, P.-J.;Chen, D.-S.;Kao, J.-H. |
| 國立成功大學 |
2019 |
More than an “inverted-U”? An exploratory study of the association between the catechol-o-methyltransferase gene polymorphism and executive functions in Parkinson’s disease
|
Fang, Y.-J.;Tan, C.-H.;Tu, S.-C.;Liu, C.-Y.;Yu, R.-L. |
| 臺大學術典藏 |
2018-09-10T14:50:58Z |
Evaluation of abdominal ultrasonography mass screening for hepatocellular carcinoma in Taiwan
|
Yeh, Y.-P. ; Hu, T.-H. ; Cho, P.-Y. ; Chen, H.-H. ; Yen, A.M.-F. ; Chen, S.L.-S. ; Chiu, S.Y.-H. ; Fann, J.C.-Y. ; Su, W.-W. ; Fang, Y.-J. ; Chen, S.-T. ; San, H.-C. ; Chen, H.-P. ; Liao, C.-S.; HSIU-HSI CHEN |
| 臺大學術典藏 |
2018-09-10T09:14:16Z |
Randomised clinical trial: High-dose vs. standard-dose proton pump inhibitors for the prevention of recurrent haemorrhage after combined endoscopic haemostasis of bleeding peptic ulcers
|
Chen, C.-C. and Lee, J.-Y. and Fang, Y.-J. and Hsu, S.-J. and Han, M.-L. and Tseng, P.-H. and Liou, J.-M. and Hu, F.-C. and Lin, T.-L. and Wu, M.-S. and Wang, H.-P. and Lin, J.-T.; Chen, C. -C.;Lee, J. -Y.;Fang, Y. -J.;Hsu, S. -J.;Han, M. -I.;Tseng, P. -H.;Liou, J. -M.;Hu, F. -C.;Lin, T. -I.;Wu, M. -S.;Wang, H. -P.;Lin, J. -T.; Chen, C.-C.;Lee, J.-Y.;Fang, Y.-J.;Hsu, S.-J.;Han, M.-I.;Tseng, P.-H.;Liou, J.-M.;Hu, F.-C.;Lin, T.-I.;Wu, M.-S.;Wang, H.-P.;Lin, J.-T.; 林肇堂 ;徐士哲 ;王秀伯 ;李基裕 ;劉志銘 ;吳明賢 ;陳建全 ;方佑仁 ;陳介章 ;曾屏輝; 林肇堂;徐士哲;王秀伯;李基裕;劉志銘;吳明賢;陳建全;方佑仁;陳介章;曾屏輝; PING-HUEI TSENG; Chen, C.-C.; Chen, C. -C.; Lee, J. -Y.; Lee, J.-Y.; JYH-MING LIOU; Fang, Y.-J.; Fang, Y. -J.; MING-SHIANG WU; Hsu, S. -J.; Hsu, S.-J.; Han, M.-I.; Han, M. -I.; Tseng, P.-H.; Tseng, P. -H.; Liou, J. -M.; Liou, J.-M.; Hu, F. -C.; Hu, F.-C.; Lin, T.-I.; Lin, T. -I.; Wu, M. -S.; Wu, M.-S.; Wang, H. -P.; Wang, H.-P.; Lin, J.-T.; Lin, J. -T.; 王秀伯; 陳建全 |
| 臺大學術典藏 |
2018 |
Systematic Review with Meta-Analysis: Concomitant Therapy vs. Triple Therapy for the First-Line Treatment of Helicobacter pylori Infection
|
Helicobacter Consortium; for the Taiwan Gastrointestinal Disease; Liou J.-M.; Lin J.-T.; MING-SHIANG WU; Fang Y.-J.; Chen C.-C.; Chen Y.-N.; Chen C.-C.; Chen M.-J. |
| 國立成功大學 |
2018 |
Visible illumination enhanced nonenzymatic glucose photobiosensor based on TiO 2 nanorods decorated with au nanoparticles
|
Wang, S.-H.;Chang, S.-J.;Hsu, C.-L.;Fang, Y.-J. |
| 國立成功大學 |
2017 |
Nonenzymatic Glucose Sensor Based on Au/ZnO Core-Shell Nanostructures Decorated with Au Nanoparticles and Enhanced with Blue and Green Light
|
Hsu, C.-L.;Fang, Y.-J.;Hsueh, T.-J.;Wang, S.-H.;Chang, S.-J. |
| 臺大學術典藏 |
2016 |
Levofloxacin sequential therapy vs levofloxacin triple therapy in the second-line treatment of helicobacter pylori: A randomized trial
|
Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Chang W.-H.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hung H.-W.; Lin J.-T.; Chang C.-Y.; MING-SHIANG WU; Fang Y.-J.; Tseng C.-H.; Chen C.-C.; Chen M.-J.; Lee Y.-C.; Chen C.-C.; Bair M.-J.; Liou J.-M. |
| 臺大學術典藏 |
2015 |
Distinct aetiopathogenesis in subgroups of functional dyspepsia according to the Rome III criteria
|
Fang Y.-J.; Liou J.-M.; Chen C.-C.; Lee J.-Y.; Hsu Y.-C.; Chen M.-J.; Tseng P.-H.; Chen C.-C.; Chang C.-Y.; Yang T.-H.; Chang W.-H.; Wu J.-Y.; Wang H.-P.; Luo J.-C.; Lin J.-T.; Shun C.-T.; MING-SHIANG WU |
| 國立臺灣大學 |
2012 |
Randomised clinical trial: high-dose vs. standard-dose proton pump inhibitors for the prevention of recurrent haemorrhage after combined endoscopic haemostasis of bleeding peptic ulcers
|
Chen, C.-C.; Lee, J.-Y.; Fang, Y.-J.; Hsu, S.-J.; Han, M.-I.; Tseng, P.-H.; Liou, J.-M.; Hu, F.-C.; Lin, T.-I.; Wu, M.-S.; Wang, H.-P.; Lin, J.-T.; 林肇堂; 徐士哲; 王秀伯; 李基裕; 劉志銘; 吳明賢; 陳建全; 方佑仁; 陳介章; 曾屏輝 |
| 國立臺灣大學 |
2012 |
Randomised clinical trial: high-dose vs. standard-dose proton pump inhibitors for the prevention of recurrent haemorrhage after combined endoscopic haemostasis of bleeding peptic ulcers
|
Chen, C. -C.; Lee, J. -Y.; Fang, Y. -J.; Hsu, S. -J.; Han, M. -I.; Tseng, P. -H.; Liou, J. -M.; Hu, F. -C.; Lin, T. -I.; Wu, M. -S.; Wang, H. -P.; Lin, J. -T.; 林肇堂; 徐士哲; 王秀伯; 李基裕; 劉志銘; 吳明賢; 陳建全; 方佑仁; 陳介章; 曾屏輝 |
